PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
57.79%
Revenue growth similar to MTDR's 58.66%. Walter Schloss would see if both companies share industry tailwinds.
142.67%
Gross profit growth at 50-75% of MTDR's 193.58%. Martin Whitman would question if cost structure or brand is lagging.
1020.37%
EBIT growth above 1.5x MTDR's 560.40%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1020.37%
Operating income growth above 1.5x MTDR's 560.40%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
253.38%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
234.15%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
234.15%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
13.36%
Share count expansion well above MTDR's 5.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.36%
Diluted share count expanding well above MTDR's 0.50%. Michael Burry would fear significant dilution to existing owners' stakes.
-5.49%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-46.73%
Negative OCF growth while MTDR is at 62.95%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-90.26%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-76.60%
Negative 10Y revenue/share CAGR while MTDR stands at 528.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-45.44%
Negative 5Y CAGR while MTDR stands at 131.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-47.79%
Negative 3Y CAGR while MTDR stands at 19.94%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-94.94%
Negative 10Y OCF/share CAGR while MTDR stands at 188.68%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-87.00%
Negative 5Y OCF/share CAGR while MTDR is at 501.31%. Joel Greenblatt would question the firm’s operational model or cost structure.
-91.44%
Negative 3Y OCF/share CAGR while MTDR stands at 26.31%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-20.96%
Negative 10Y net income/share CAGR while MTDR is at 232.09%. Joel Greenblatt sees a major red flag in long-term profit erosion.
2617.93%
5Y net income/share CAGR above 1.5x MTDR's 480.00%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
182.96%
3Y net income/share CAGR above 1.5x MTDR's 76.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-64.84%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-41.72%
Negative 5Y equity/share growth while MTDR is at 3.15%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-5.06%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-91.06%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.28%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-77.60%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
77.76%
AR growth well above MTDR's 28.60%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
0.29%
Asset growth well under 50% of MTDR's 15.14%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-6.04%
We have a declining book value while MTDR shows 26.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.10%
We’re deleveraging while MTDR stands at 0.01%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
2.27%
SG&A declining or stable vs. MTDR's 4.85%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.